MRI may suggest alternative diagnoses or determine extent of cholangiocarcinomas, assessing extent of the tumor within the bile ducts, lobar atrophy, vascular invasion, and metastatic disease. In particular, MRI may be valuable in identifying isolated bile ducts that are not delineated on more invasive studies such as ERCP or percutaneous cholangiography. Cholangiocarcinoma uniquely retains conventional gadolinium contrast agents on delayed imaging, and thus, our MRI protocol will be specifically optimized to detecting and staging it if this clinical suspicion is noted on the exam request.
- Manfredi R, Barbaro B, Masselli G, Vecchioli A, Marano P. Magnetic resonance imaging of cholangiocarcinoma. Semin Liver Dis 2004; 24:155-164. PubMed link
- Masselli G, Gualdi G. Hilar cholangiocarcinoma: MRI/MRCP in staging and treatment planning. Abdom Imaging 2008; 33:444-451. PubMed link
- Masselli G, Manfredi R, Vecchioli A, Gualdi G. MR imaging and MR cholangiopancreatography in the preoperative evaluation of hilar cholangiocarcinoma: correlation with surgical and pathologic findings. Eur Radiol 2008; 18:2213-2221. PubMed link
- Kim JE, Lee JM, Kim SH, et al. Differentiation of intraductal growing-type cholangiocarcinomas from nodular-type cholangiocarcinomas at biliary MR imaging with MR cholangiography. Radiology 2010; 257:364-372. PubMed link
- Maetani Y, Itoh K, Watanabe C, et al. MR imaging of intrahepatic cholangiocarcinoma with pathologic correlation. AJR Am J Roentgenol 2001; 176:1499-1507. PubMed link
Last modified Thu, 9 Aug, 2012 at 14:27